The panel included previously reported endometrial cancer stem cell markers [12, 13, 14] (CD44, ALDH1 and CD133), normal endometrial stem cell markers [15] (SOX9 and CD15) and universal stem cell marker [16]. The gene discussed is CD44; the disease is endometrial cancer.